EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dysregulated miRNA Expression and Androgen Receptor Loss in Racially Distinct Triple-Negative Breast Cancer

Shristi Bhattarai, Bruna M Sugita, Emanuelle Nunes-Souza, Aline S Fonseca iD, Darshan Shimoga Chandrashekar iD, Mahak Bhargava iD, Luciane R Cavalli, Ritu Aneja iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252413679 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Shristi Bhattarai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Biology, Kennesaw State University, Kennesaw, GA 30144, USA. Hauptthemen laut MEDLINE: Black or African American, Gene Expression Regulation, Neoplastic, MicroRNAs, Receptors, Androgen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute, NIH/NCI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Androgen receptor (AR)-negative triple-negative breast cancer (TNBC), often termed quadruple-negative breast cancer (QNBC), disproportionately impacts women of African descent, leading to poorer overall survival (OS). MiRNAs regulate the expression of gene drivers involved in critical signaling pathways in TNBC, such as the AR gene, and their expression varies across races and breast cancer subtypes. This study investigates whether differentially expressed miRNAs influence AR transcription, potentially contributing to the observed disparities between African American (AA) and European American (EA) QNBC patients. Race-annotated TNBC samples (n = 129) were analyzed for AR expression status and revealed the prevalence of QNBC in AA patients compared to EA (76.6% vs. 57.7%) and a significant association of AR loss with poor survival among AAs. The Cancer Genome Atlas (TCGA) RNA-seq data showed that AAs with TNBC (n = 32) had lower AR mRNA levels than EAs (n = 67). Among TCGA patients in the AR-low group, AAs had significantly poorer OS than EAs. In our cohort, 46 miRNAs exhibited differential expression between AAs and EAs with QNBC. Ten of these miRNAs (miR-1185-5p, miR-1305, miR-3161, miR-3690, miR-494-3p, miR-509-3-5p, miR-619-3p, miR-628-3p, miR-873-5p, and miR-877-5p) were predicted to target the AR gene/signaling. The loss of AR expression is linked to poorer prognoses in AA women. The understanding of the specific miRNAs involved and their regulatory mechanisms on AR expression could provide valuable insights into why AA women are more prone to QNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Black or African AmericanGene Expression Regulation, NeoplasticMicroRNAsReceptors, AndrogenTriple Negative Breast NeoplasmsAdultAgedFemaleHumansMiddle AgedBiomarkers, TumorPrognosisWhite

Stichwörter der Autor:innen

androgen receptormiRNAprognosisquadruple negativeracetriple-negative breast cancer

Substanzen

AR protein, humanBiomarkers, TumorMicroRNAsReceptors, Androgen

Autor:innen und Institutionen

  • Department of Molecular and Cellular Biology, Kennesaw State University, Kennesaw, GA 30144, USA.
  • Department of Biology, Georgia State University, Atlanta, GA 30302, USA.
  • Research Institute Pelé Pequeno Príncipe, Faculdades Pequeno Príncipe, Curitiba 80250-060, PR, Brazil.
  • Molecular and Cellular Pathology, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
  • Department of Nutrition Sciences, School of Health Professions, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
  • Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20007, USA.

ORCID-Profile: Aline S Fonseca, Darshan Shimoga Chandrashekar, Mahak Bhargava, Ritu Aneja

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • NIH/NCI

Zitieren

APA

Bhattarai, S., Sugita, B. M., Nunes-Souza, E., Fonseca, A. S., Chandrashekar, D. S., Bhargava, M., Cavalli, L. R., & Aneja, R. (2024). Dysregulated miRNA Expression and Androgen Receptor Loss in Racially Distinct Triple-Negative Breast Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252413679

Vancouver

Bhattarai S, Sugita BM, Nunes-Souza E, Fonseca AS, Chandrashekar DS, Bhargava M, et al. Dysregulated miRNA Expression and Androgen Receptor Loss in Racially Distinct Triple-Negative Breast Cancer. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252413679

BibTeX
@article{Bhattarai2024,
  author = {Bhattarai, Shristi and Sugita, Bruna M and Nunes-Souza, Emanuelle and Fonseca, Aline S and Chandrashekar, Darshan Shimoga and Bhargava, Mahak and Cavalli, Luciane R and Aneja, Ritu},
  title = {Dysregulated miRNA Expression and Androgen Receptor Loss in Racially Distinct Triple-Negative Breast Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252413679}
}
Kostenlos starten →